Public Act 097-0198
 
HB1825 EnrolledLRB097 05082 RPM 45123 b


  
    AN ACT concerning insurance.
  
 
    Be it enacted by the People of the State of Illinois,
 
represented in the General Assembly:
  
 
 
    Section 5. The Illinois Insurance Code is amended  by adding 
Section 356z.19 as follows:
 
    (215 ILCS 5/356z.19 new)
    Sec. 356z.19. Cancer drug parity.
    (a) As used in this Section:
    "Financial requirement" means deductibles, copayments,

coinsurance, out-of-pocket expenses, aggregate lifetime

limits, and annual limits.
    "Treatment limitation" means limits on the frequency of

treatment, days of coverage, or other similar limits on the

scope or duration of treatment.
    (b) On and after the effective date of this amendatory Act

of the 97th General Assembly, every insurer that amends,

delivers, issues, or renews an individual or group policy of

accident and health insurance amended, delivered, issued, or

renewed on or after the effective date of this amendatory Act

of the 97th General Assembly that provides coverage for

prescribed orally-administered cancer medications and

intravenously administered or injected cancer medications

shall ensure that:
        (1) the financial requirements applicable to such

    prescribed orally-administered cancer medications are no

    more restrictive than the financial requirements applied

    to intravenously administered or injected cancer

    medications that are covered by the policy and that there

    are no separate cost-sharing requirements that are

    applicable only with respect to such prescribed

    orally-administered cancer medications; and
        (2) the treatment limitations applicable to such

    prescribed orally-administered cancer medications are no 
    more restrictive than the treatment limitations applied to

    intravenously administered or injected cancer medications

    that are covered by the policy and that there are no

    separate treatment limitations that are applicable only

    with respect to such prescribed orally-administered cancer

    medications. 
    (c) An insurer cannot achieve compliance with this Section

by increasing financial requirements or imposing more

restrictive treatment limitations on prescribed 
orally-administered cancer medications or intravenously

administered or injected cancer medications covered under the

policy on the effective date of this amendatory Act of the 97th

General Assembly.